Ultima Genomics, Inc.
Novel sequencing-by-synthesis chemistry and platform for high-throughput DNA sequencing
New patent ·
- Sector
- Biotech
- Headquarters
- Newark, CA
- Total capital
- $5.7M
- Federal grants
- $4.5M
- 3 awards · 2019–2021
- Rank in peer group#7 of 13
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.2M
- 3 awards · Health and Human S
- Rank in Biotech#176 of 4373
- Granted patents
- 15
- 25 pending · first 2025
- Rank in peer group#1 of 13
Capital timeline
Latest events
- Federal contractHealth and Human S · Purchase Of Ultima Genomics Reagents, New Po$147K
- Federal contractHealth and Human S · This Reagent Is Needed By Chloe Buchter For Preparation Of Dna Libraries For Sequencing For Dr. Dan Kastner. The Reagents Being Ordered Will Support Project Kastner Nf Grasp, Initiated On 04/04/2014 By Dr. Kastner At Nhgri.$20K
- Federal contractHealth and Human S · Ultima Genomics UG100-V Dna Sequencer$1M
- Federal grantHealth and Human S · Phase II · Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing$618K
- Federal grantHealth and Human S · Phase II · Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing$2M
- Federal grantHealth and Human S · Phase II · Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing$1.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 13 peers
Line = medianBiotech · System
- Federal grants#7 · top 54%
- Granted patents#1 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 15 granted of 40- New patentMethods And Systems For Determining Sequencing Read DistancesUSPTOUS 12,760,359
- New patentMethods For Preparing A Library Of Polynucleotide MoleculesUSPTOUS 12,753,405
- PendingSystems And Methods For Processing AnalytesUSPTOApplication 19569858
Show all 40 patent records
- Methods And Systems For Determining Sequencing Read DistancesOct 13, 2026 · US 12,760,359Granted
- Methods For Preparing A Library Of Polynucleotide MoleculesOct 6, 2026 · US 12,753,405Granted
- Systems And Methods For Processing AnalytesSep 10, 2026 · Application 19569858Pending
- Systems And Methods Using Photonic Structure SubstratesSep 8, 2026 · US 12,730,072Granted
- Methods, Devices, And Systems For Analyte Detection And AnalysisAug 6, 2026 · Application 19460975Pending
- Sequencing ReagentsAug 6, 2026 · Application 19458032Pending
- Systems, Methods, And Compositions For SequencingJul 30, 2026 · Application 19313329Pending
- Methods And Systems For Substrate FunctionalizationJul 14, 2026 · US 12,678,822Granted
- Methods Of Sequencing Nucleic Acid MoleculesJul 7, 2026 · US 12,674,199Granted
- Sequencing With ConcatemerizationJul 2, 2026 · Application 19179090Pending
- Rna Sequencing MethodsJun 25, 2026 · Application 19417118Pending
- Systems And Methods For Focus CorrectionJun 18, 2026 · Application 19400960Pending
- Methods And Systems For Phasing Sequencing Strands And Long-range SequencingMay 26, 2026 · US 12,637,713Granted
- Methods And Systems For Analyte Detection And AnalysisMay 21, 2026 · Application 19362964Pending
- Systems And Methods For Nucleic Acid Mismatch Error DetectionMay 14, 2026 · Application 19278437Pending
- Systems And Methods For Spatial Screening Of AnalytesApr 30, 2026 · Application 19178718Pending
- Systems And Methods For Nucleic Acid Mismatch Error Detection ApplicationsApr 23, 2026 · Application 19301428Pending
- Methods For Detecting Nucleic Acid VariantsApr 23, 2026 · Application 19367611Pending
- Nucleic Acid Clonal Amplification And Sequencing Methods, Systems, And KitsApr 16, 2026 · Application 19256427Pending
- Methods For Detecting Nucleic Acid VariantsApr 2, 2026 · Application 19324558Pending
- Methods For Nucleic Acid AnalysisMar 19, 2026 · Application 19282712Pending
- Methods, Devices, And Systems For Analyte Detection And AnalysisMar 10, 2026 · US 12,571,036Granted
- Methods And Systems For Nucleic Acid AnalysisFeb 26, 2026 · Application 19286581Pending
- Rna Sequencing MethodsJan 13, 2026 · US 12,522,867Granted
- Systems And Methods For Library Preparation AdaptersJan 8, 2026 · Application 19261379Pending
- Novel Illumination And Background Rejection For Enhanced Resolution ImagingDec 11, 2025 · Application 19232376Pending
- Linkers And Methods For Optical Detection And SequencingDec 4, 2025 · Application 19240863Pending
- Methods And Systems For Analyte Detection And AnalysisNov 25, 2025 · US 12,480,938Granted
- Methods For Detecting Nucleic Acid VariantsNov 25, 2025 · US 12,482,536Granted
- Quantification Of Co-localized Tag Sequences Using Orthogonal Sequence EncodingNov 13, 2025 · Application 19236815Pending
- Methods For Detecting Nucleic Acid VariantsOct 7, 2025 · US 12,437,839Granted
- Enhanced Resolution ImagingSep 11, 2025 · Application 19090897Pending
- Methods And Systems For Counter Scan Area Mode ImagingAug 28, 2025 · Application 19198945Pending
- Methods And Systems For Nucleic Acid AnalysisAug 26, 2025 · US 12,397,300Granted
- Implementing Barriers For Controlled Environments During Sample Processing And DetectionAug 21, 2025 · Application 19037820Pending
- Linkers And Methods For Optical Detection And SequencingAug 5, 2025 · US 12,378,600Granted
- Nucleic Acid Clonal Amplification And Sequencing Methods, Systems, And KitsAug 5, 2025 · US 12,378,593Granted
- Systems And Methods For Nucleic Acid SequencingJun 19, 2025 · Application 18974424Pending
- Accelerated Sequencing MethodsJun 19, 2025 · Application 18983045Pending
- Methods For Nucleic Acid AnalysisJun 3, 2025 · US 12,319,959Granted
Related companies, and why
- EVESTRA, INC.Similar federal contract value in Biotech · $1.2M in contracts
- APPLIED STEMCELL, INC.Similar federal contract value in Biotech · $1.2M in contracts
- Akron Biotechnology, LLCSimilar federal contract value in Biotech · $1.2M in contracts
- VIRTICI LLCSimilar federal contract value in Biotech · $1.2M in contracts
- Htg Molecular Diagnostics, IncSimilar federal contract value in Biotech · $1.2M in contracts
- EXTEND BIOSCIENCES INCSimilar federal contract value in Biotech · $1.1M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .